Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

medRxiv logoLink to medRxiv
[Preprint]. 2026 Jan 13:2026.01.11.26343883. [Version 1] doi: 10.64898/2026.01.11.26343883

Estimating enteric fever seroincidence in Bangladesh using rapid serosurveys

Sira Jam Munira 1,†, Naito Kanon 2,†, Nahidul Islam 3, Shakiul Kabir 4, Anik Sarkar 5, Shamsul Alam Polash 6, Hafizur Rahman 7, Alice S Carter 8, Richelle C Charles 9, Jason R Andrews 10, Stephen P Luby 11, Kristen Aiemjoy 12, Denise O Garrett 13,‡, Samir K Saha 14,‡, Jessica C Seidman 15,‡,*, Senjuti Saha 16,‡,*
PMCID: PMC12870607  PMID: 41646783

Abstract

Background

Enteric fever, caused by Salmonella Typhi or Paratyphi, is a major public health issue in low-and middle-income countries. Accurate burden estimation is hampered by limited microbiological facilities and low sensitivity of blood culture tests. Serosurveillance offers a scalable alternative to address these challenges. This study estimated the seroincidence of enteric fever in Bangladesh using cross-sectional rapid serosurveys.

Methods

School-based surveys (January-June 2022) were conducted in Chattogram, Dinajpur, Sylhet, Satkhira, and Faridpur, and community-based surveys (July 2019-November 2021) were conducted in Dhaka and Mirzapur. Blood samples (dried blood spots or venous blood) were collected and tested for anti-Hemolysin E IgG responses using a kinetic Enzyme-linked Immunosorbent Assay. Seroincidence was estimated using a maximum likelihood approach based on peak antibody titers and decay rates, modelled from blood-culture confirmed enteric fever cases in Bangladesh.

Findings

A total of 2,969 participants aged 0–22 years were enrolled, with 75.5% aged 5–15 years. Seroincidence rates (per 100 person-years) were highest in Dhaka (33.1; 95% confidence interval [CI], 29.0–37.9), followed by Mirzapur (19.5; 95%CI, 17.4–21.7) and Chattogram (17.1; 95% CI, 15.0–19.4), and the lowest in Faridpur (11.1; 95%CI, 9.6–12.7). The under 5 age group exhibited higher rates in Dhaka (40.3; 95%CI, 32.1–50.7) and Mirzapur (26.1; 95%CI, 21.0–32.4) compared to older age groups. Seroincidence was elevated in areas with higher population density.

Conclusions

This study highlights a substantial burden of enteric fever infections across Bangladesh. These provide important evidence to guide post-introduction monitoring and optimization of the typhoid conjugate vaccine program in the national immunization schedule.

Keywords: Seroincidence, Salmonella Typhi, Salmonella Paratyphi, Hemolysin E, Bangladesh

INTRODUCTION

Enteric fever, caused by Salmonella enterica serovar Typhi and Paratyphi A, B, or C, remains a significant cause of mortality and morbidity in low- and middle-income countries [1]. Globally, it accounts for an estimated 9.2 million cases and 110,000 deaths annually, with South Asia bearing the highest burden (379/100,000 person-years) [2]. Dhaka, the capital of Bangladesh, has one of the highest reported clinical incidence rates globally, with an estimated 913/100,000 person-years for typhoid and 128/100,000 person-years for paratyphoid [3]. Clinical surveillance data show the highest incidence among children under 5 years, particularly those aged 2–4 years, followed closely by school-aged children [3,4].

Prior studies of typhoid incidence in Bangladesh have reported blood culture-based incidence data primarily from Dhaka, where microbiological laboratory facilities for blood culture, the reference standard for diagnosis, are available at multiple institutions [3,5]. Blood culture has limited sensitivity (~60%) due to factors such as low pathogen load and prior antibiotic use [6]. Accurately estimating population-level incidence requires continuous surveillance and broad access to health facilities equipped for blood culture, both of which still remain key challenges. Without comprehensive surveillance, incidence estimates across the country may be incomplete, hampering evidence-based policy decisions like vaccine prioritization [7].

Serosurveillance has emerged as a practical and scalable tool to estimate population-level infection burden, particularly in resource-constrained settings. This approach has been successfully used for infectious diseases such as COVID-19, dengue, and hepatitis E [8–11]. Historically, the Vi capsular polysaccharide antigen was used as a serologic marker for typhoid fever. However, Vi has several drawbacks: it cannot distinguish between natural infection and Vi-based vaccination, performs poorly in detecting acute infections and paratyphoid cases, and does not show age-related variation in endemic settings [12–14]. Recent studies have identified Salmonella Typhi Hemolysin E (HlyE), a pore-forming toxin, as a promising serological marker for exposure to enteric fever [15,16]. These markers have also been further validated for use in population-based serosurveillance for enteric fever, demonstrating a strong correlation with clinical incidence estimates [17]. Previous studies utilizing these serological markers and employing a representative population-level sampling approach have reported seroincidence estimates in Bangladesh, Nepal, Pakistan, Ghana, South Sudan, India, and Kenya [17–20].

To address gaps in clinical surveillance and better understand the burden of enteric fever across diverse regions of Bangladesh, this study aimed to estimate seroincidence using a school-based sampling approach. This sampling strategy could be a practical approach to conduct serosurveys rapidly and efficiently. We also incorporated a mix of urban, semi-urban, and rural regions to evaluate the diversity of enteric fever burden and the pattern of infection nationally. These findings are intended to inform evidence-based policies for the strategic implementation and post-introduction monitoring of the typhoid conjugate vaccine in Bangladesh.

METHODS

Study design, sites, and population

This cross-sectional study estimated the seroincidence of enteric fever across seven geographically diverse regions in Bangladesh. We conducted school- and community-based serosurveys to capture representative data from urban, semi-urban, and rural populations, including participants aged 0–22 years. For community-based surveys in Dhaka and Mirzapur, we randomly selected sampling grid clusters within specific catchment areas, where prior healthcare utilization surveys and ongoing demographic surveillance had been conducted [21,22]. All households in each selected cluster were enumerated, and an age-stratified random sample of participants aged 0–18 years was drawn. Details of catchment areas and randomization procedures for selecting sampling grids, households, and participants have been published previously [3,17,21]. Inclusion criteria were age (0–18 years) and residence within catchment areas. Participants were enrolled between July 2019 and November 2021.

For school-based surveys, we selected eight schools from four districts — Chattogram, Dinajpur, Sylhet, and Satkhira — and enrolled participants aged 4–18 years. Additionally, we included four project schools in Faridpur and enrolled participants aged 1–22 years old. These project schools served local communities by offering day care services, meals, and education. All surveys were conducted between January and June 2022. We selected districts representing urban, rural, and semi-urban communities across the central, northeastern, northwestern, southwestern, and southeastern regions of Bangladesh. Population densities were estimated using GPS location data collected during enrolment [23]. The schools were selected based on ease of transportation, logistical feasibility, and existing collaborations with the school authorities and local governing bodies. Within schools, participants were randomly selected from student registries. Teachers notified parents/guardians in advance about their child’s selection and requested informed consent. A study team comprising 13–15 members completed each survey within 3–4 days (Figure 1 and Supplementary Table 1).

Figure 1.

Figure 1.

Overview of study areas, sampling procedure, and characteristics of study participants.

Data collection

The study team administered a pre-tested, semi-structured questionnaire to collect socio-demographics, including age and sex, as well as health-related information such as self-reported episodes of fever in the past six months, typhoid diagnoses within the last year, and any history of typhoid vaccination. In community-based surveys, trained health workers administered questionnaires to parents/guardians during pre-scheduled home visits. In school-based surveys, the study team collected sociodemographic information from students during sample collection, when applicable. Later, they verified through follow-up phone calls with parents/guardians to ensure completeness and accuracy.

Sample collection, storage, and laboratory procedure

Blood samples were collected using two different methods, based on the survey settings and logistical considerations (Figure 1). In the community-based serosurveys, finger stick capillary blood samples were collected onto TropBioTM filter paper (Cellabs, Brookvale, NSW, Australia) and stored as dried blood spots (DBS). Samples were air-dried for at least 2 hours at room temperature, sealed in air-tight plastic bags with desiccant, and transported to the central laboratory, where they were stored at −20°C until further processing. In school-based surveys, venous blood samples were collected at the request of the schools to include screening tests (blood grouping and Hepatitis B/C testing) to benefit the participants and local communities. Using aseptic technique, 2–3 mL of venous blood was collected in EDTA (Ethylenediamine tetraacetic acid) tubes. Approximately two-thirds of each blood sample was centrifuged to obtain plasma, while the remaining one-third was preserved in EDTA as whole blood. All samples were initially stored at 4°C locally and transported to our central laboratory in Dhaka within 72 hours, ensuring the temperature was maintained throughout. Whole blood was used for blood grouping, and plasma for Hepatitis B or C testing. After completion of the tests, the plasma samples were preserved at −20°C until further processing.

IgG antibody responses against HlyE were measured using kinetic enzyme-linked immunosorbent assays (K-ELISAs) and normalized to positive controls. Descriptions of DBS elution protocol, ELISA protocol, and serological analysis are available in previous publications [16,17,24] and in Supplementary Document.

Statistical analysis

Our target sample size was at least 400 per area, as detailed in the supplementary materials. Seroincidence rates were estimated based on quantified anti-HlyE IgG antibody responses using a likelihood function constructed to model the observed cross-sectional antibody data. Incident infections were assumed to occur as a Poisson process. The likelihood function represents each individual’s antibody measurement as the product of antibody responses following infection, measurement variability, and baseline biological reactivity. Antibody responses after infection, including peak responses and decay rates, were parameterized using a previously published longitudinal cohort of blood-culture-confirmed enteric fever cases enrolled in Nepal, Pakistan, and Bangladesh [17], and incorporated directly into the likelihood to characterize expected temporal antibody trajectories following infection. Measurement error was quantified using the coefficient of variation across assay replicates, and biological noise was defined using responses among confirmed unexposed negative controls [17,18,25]. For this study, we used unstratified and age-stratified antibody decay dynamics modelled from a subset of 407 blood-culture confirmed cases enrolled in Bangladesh [26]. Seroincidence estimates were calculated for each of the seven study sites. Age-stratified analyses were conducted for three groups: under 5 years, 5–15 years, and 16 years and older. We also conducted a sensitivity analysis using pooled multi-country kinetics to assess differences in seroincidence estimates [17].

All statistical analyses were performed using R version 4.2.2 and the serocalculator package 1.3.0 [27]. Confidence intervals for seroincidence estimates were computed at the 95% level.

RESULTS

Study population characteristics

A total of 2,969 participants were enrolled across seven regions of Bangladesh (Figure 1). 997 (33.6%) were from community-based surveys, and 1972 (66.4%) were enrolled in school-based surveys. The majority of the participants (2243/2969, 75.5%) were aged 5–15 years. The median age of participants varied by region, ranging from 9–14 years, and females constituted 54.9% (1630/2969) of the participants. About 12.5% (371/2969) of participants reported having a fever within the past six months, and only 2.8% (84/2969) reported a prior diagnosis of typhoid fever. Most participants (2937/2969, 98.9%) reported never receiving a typhoid vaccine in their lifetime (Table 1).

Table 1.

Characteristics of the study participants.

Characteristics Dhaka (n=401) Mirzapur (n=596) Chattogram (n=395) Dinajpur (n=393) Sylhet (n=389) Satkhira (n=400) Faridpur (n=395)
Median age in years (IQR) 9.2 (4.9–14) 9.9 (4.9– 14.5) 10 (9–13) 11 (9–13) 14 (12–16) 13 (11–15) 9 (6–14)
Age categories
Under 5 years (%) 101 (25.2%) 151 (25.3%) 0 (0.0%) 2 (0.5%) 1 (0.3%) 0 (0.0%) 62 (15.7%)
5–15 years (%) 256 (63.8%) 360 (60.4%) 380 (96.2%) 372 (94.7%) 283 (72.8%) 347 (86.8%) 245 (62.0%)
16 years and older (%) 44 (11.0%) 85 (14.3%) 15 (3.8%) 19 (4.8%) 105 (26.9%) 53 (13.3%) 88 (22.3%)
Female (%) 218 (54.4%) 299 (50.2%) 282 (71.4%) 213 (54.2%) 186 (47.8%) 241 (60.3%) 191 (48.4%)
Self- reported fever episodes in the past six months
Yes (%) 40 (10.0%) 121 (20.3%) 43 (10.9%) 40 (10.2%) 42 (10.8%) 45 (11.3%) 40 (10.1%)
No (%) 361 (90.0%) 475 (79.7%) 350 (88.6%) 252 (64.1%) 346 (88.9%) 354 (88.5%) 322 (81.5%)
Donť know (%) 0 (0.0%) 0 (0.0%) 2 (0.5%) 101 (25.7%) 1 (0.26%) 1 (0.3%) 33 (8.4%)
History of typhoid diagnosis
Yes (%) 25 (6.2%) 4 (0.7%) 16 (4.1%) 14 (3.6%) 7 (1.8%) 6 (1.5%) 12 (3.0%)
No (%) 376 (93.8%) 592 (99.3%) 378 (95.7%) 283 (72.0%) 381 (97.9%) 389 (97.3%) 355 (89.9%)
Donť know (%) 0 (0.0%) 0 (0.0%) 1 (0.3%) 96 (24.4%) 1 (0.3%) 5 (1.3%) 28 (7.1%)
No typhoid vaccination (%) 371 (92.5%) 596 (100%) 395 (100%) 393 (100%) 388 (99.8%) 399 (99.8%) 395 (100%)
*

IQR, Interquartile range.

Regional seroincidence

Anti-HlyE IgG responses demonstrated substantial regional and age-related variation (Figure 2). Overall antibody response was highest in Dhaka with a median of 9.3 ELISA units and an interquartile range (IQR) of 4.9–18.9, followed by Chattogram (6.3; IQR, 3.4–10.2) and Mirzapur (5.4; IQR, 3.1–9.1), while they were comparatively lower in Faridpur (3.7; IQR, 1.8–7) (Figure 2A). These differences in responses were statistically significant (p<0.0001) across all areas compared to Dhaka. Antibody responses increased with age in all seven regions. Dhaka consistently exhibited the highest responses amongst all ages (Figure 2B).

Figure 2.

Figure 2.

Anti-HlyE IgG responses among study participants A) by study areas B) by age. Each dot represents each participant’s anti-Hemolysin E IgG responses results; Box plots represent median responses with the Interquartile range (IQR) across areas.

The overall seroincidence (per 100 person-years) was highest in Dhaka (33.1; 95%CI, 29.0–37.9) and then in Mirzapur (19.5; 95%CI, 17.4–21.7), both of which were assessed through community-based surveys. In comparison, school-based surveys conducted in the remaining areas reported lower seroincidence estimates: Chattogram (17.1; 95%CI, 15.0–19.4), Dinajpur (14.4; 95%CI, 12.6–16.3), Sylhet (12.6; 95%CI, 11.0–14.4), Satkhira (11.5; 95%CI, 10.1–13.0), and Faridpur (11.1; 95%CI, 9.6–12.7) (Table 2, Figure 3). While differences in survey approach may have contributed, these patterns also align with population density, with higher seroincidence observed in more densely populated areas (r=0.87) (Supplementary Figure 1).

Table 2.

Estimated seroincidence of enteric fever in Bangladesh.

Study areas Seroincidence per 100 person-years* (95% CI**)
Overall Under 5 years 5–15 years 16 and older years
Dhaka 33.1 (29.0–37.9) 40.3 (32.1–50.7) 30.1 (25.5– 35.5) 22.9 (14.9–35.3)
Mirzapur 19.5 (17.4–21.7) 26.1 (21.0–32.4) 18.2 (16.0– 20.8) 14.9 (11.1– 20.0)
Chattogram 17.1 (15.0–19.4) Not applicable 17.0 (14.9–19.3) Not applicable
Dinajpur 14.4 (12.6–16.3) Not applicable 14.3 (12.5–16.3) Not applicable
Sylhet 12.6 (11.0–14.4) Not applicable 12.3 (10.6–14.4) 13.5 (10.5–17.4)
Satkhira 11.5 (10.1–13.0) Not applicable 11.6 (10.1–13.3) 11.0 (7.8–15.5)
Fa rid pur 11.1 (9.6–12.7) 13.7 (9.1– 20.5) 11.4 (9.7–13.6) 8.6 (6.5–11.5)
*

Bangladesh-specific pooled kinetics were used for the seroinicidence estimation. Overall seroincidence estimates were generated using Bangladesh-specific unstratified antibody kinetics. Bangladesh-specific age-stratified kinetics were applied to generate estimates in all age groups.

**

95% CI, 95% confidence interval

Figure 3.

Figure 3.

Estimated seroincidence of enteric fever per 100 person-years by age groups across seven areas. Each shape represents a seroincidence estimate with a 95% confidence interval, presented both overall and stratified by age group.

Stratified seroincidence by age, gender, and prior typhoid diagnosis

Seroincidence estimates per 100 person-years were available for children under 5 years in three areas. The highest burden was in Dhaka (40.3; 95%CI, 32.1–50.7), compared to Mirzapur (26.1; 95%CI, 21.0–32.4) and Faridpur (13.7; 95%CI, 9.1–20.5). For the 5–15 years age group, community-based sampling showed the highest burden in Dhaka (30.1; 95%CI, 25.5–35.5), followed by Mirzapur (18.2; 95%CI, 16.0–20.8). In the remaining areas, where a school-based sampling strategy was used, Chattogram had the highest seroincidence (17.0; 95%CI, 14.9–19.3), and Faridpur had the lowest (11.4; 95%CI, 9.7–13.6). For those 16 years and older, Dhaka (22.9; 95%CI, 14.9–35.3) and Mirzapur (14.9; 95%CI, 11.1–20.0) had the highest burden, while Faridpur had the lowest (8.6; 95%CI, 6.5–11.5). Seroincidence could not be estimated in this age group for Chattogram and Dinajpur due to insufficient sample size. Children under 5 consistently exhibited higher seroincidence rates than older age groups in high-burden settings. In contrast, lower-incidence areas had more uniform age distributions, suggesting potential differences in exposure patterns or transmission intensities (Table 2, Figure 3).

Seroincidence was estimated using pooled multi-country kinetics for comparison with Bangladesh-specific kinetics. Estimates based on the Bangladesh kinetics are lower in all sites and age groups because they have a slower decay rate than those based on the pooled kinetics. In a high force of infection setting such as Dhaka, pooled kinetics may overestimate seroincidence (Supplementary Table 2 and Supplementary Figure 2).

Stratified seroincidence by gender was estimated across all sites combined and separately. Overall, seroincidence estimations were slightly higher among females (16.5; 95%CI, 15.5–17.6) compared to males (14.9; 95%CI, 13.9–16.1) in all areas. Gender-specific seroincidence estimates were highest in Dhaka (Female: 33.9; 95%CI, 28.2–40.8 and Male: 32.3; 95%CI, 26.5–39.3) and lowest in Faridpur (Female: 10.4; 95%CI, 8.5–12.7 and Male: 11.8; 95%CI, 9.7–14.3). Participants with a typhoid diagnosis in the last year showed higher seroincidence (20.5; 95%CI, 15.2–27.8) compared to those without a reported typhoid diagnosis (15.9; 95%CI, 15.1–16.7) (Supplementary Table 3).

DISCUSSION

This study of 2,969 participants from seven geographically diverse regions of Bangladesh revealed a high enteric fever burden in areas where traditional blood culture surveillance data are not available. We collected plasma and fingerstick capillary blood samples through cross-sectional rapid school- and community-based surveys. While a population-based random sampling strategy is the gold standard for estimating disease burden, the school-based approach enabled low-cost, efficient sample collection with minimal logistical challenges. Additionally, the centralized nature of schools facilitated coordination with the study team during the initial preparation phase. Also, it ensured the smooth delivery of blood group and hepatitis test results to participants. This study identified substantial evidence of high enteric fever infections in rural and semiurban Bangladesh, particularly among children under 5 years, underscoring their vulnerability and the need for targeted interventions.

Our study estimated the incidence of enteric fever infections based on quantitative HlyE IgG antibody responses [17]. Our results show that while anti-HlyE IgG responses increased with age across all seven areas, the highest seroincidence rates were observed in the youngest age groups (children <5 years old). This finding is consistent with the Strategic Typhoid Alliance Across Asia and Africa (STRATAA) study in Bangladesh [28]. For the under 5 age group, our seroincidence estimates in Dhaka (40.3), Mirzapur (26.1), and Faridpur (13.7) are significantly higher compared to the older age groups. This finding suggests a high incidence of enteric fever among younger children, consistent with clinical incidence data [3,29]. The higher ratio of seroincidence to clinical incidence among young children observed here and in other seroepidemiology studies suggests that children may be more likely to have subclinical infections or that culture-confirmed infections are under-ascertained in this age group (due to the lower sensitivity of blood culture at lower volumes, for example).

Our seroincidence estimates were highly correlated with increased population densities. Dhaka, the most densely populated area, exhibited the highest seroincidence estimates per 100 person-years (33.1) among all seven regions of Bangladesh. However, previous seroincidence estimates from the SEES study (41.2), using anti-HlyE IgA and IgG responses, and STRATAA estimates (47.1) using HlyE IgG were higher than our finding [17,28].

Differences between our seroincidence estimate and that of the SEES study may reflect our use of Bangladesh-specific antibody kinetics, in contrast to the multi-country kinetics applied in SEES. In Bangladesh, IgG responses decayed more slowly in comparison to the other sites, likely explained by the higher force of infection there. When using Bangladesh-specific kinetics, time-since-infection at the population-level is longer and the seroincidence rate is therefore smaller. IgA responses are less dependent on different forces of infection and may be preferable to use in future studies to allow for more robust comparisons across sites.

Mirzapur had the second-highest seroincidence estimate (19.5), while a previous study based on clinical incidence, from 2016 to 2017, had reported it as a low-endemic area [30]. Changes over the years in population migration, improved transportation, and increasing urbanization may have influenced this shift by facilitating greater transmission of Salmonella Typhi/Paratyphi than reported historically. Alternatively, Salmonella Typhi/Paratyphi may be under detected in this area. Chattogram, the second largest city in Bangladesh, reflected the third-highest seroincidence estimate (17.1). A prior study at Chattogram found that one in five (52/300, 17.3%) non-malarial febrile patients admitted had a diagnosis of enteric fever, detected by blood culture or PCR [31]. All six rural and semi-urban areas in our study displayed considerably lower seroincidence estimates compared to Dhaka, an urban area. Although seroincidence estimates are expected to exceed clinical incidence, our findings across all seven regions and age groups still revealed high levels of enteric fever transmission, well above the clinical high burden threshold of 100 cases per 100,000 person-years [3,32]. The SEES study also showed the higher rank order of seroincidence estimates tracked with clinical enteric fever incidence estimates derived from a blood culture-based surveillance approach [17].

An important advantage of using the school-based approach is its logistical efficiency. While not fully representative of the general population, it may serve as a reasonable proxy for estimating incidence among school-aged children where clinical surveillance data are lacking. School-based sampling significantly reduces demands on time, personnel, and resources, eliminates the need for household enumeration, and reduces travel and operational costs. For example, we were able to sample a school within 3–5 days, rather than several weeks/months to conduct a population-based serosurvey. These efficiencies make school-based surveys a valuable and feasible alternative in resource-constrained environments.

This study is subject to several limitations. First, the schools were selected conveniently, which may have introduced potential selection bias and reduced the generalizability of the findings. While this approach enabled efficient implementation in resource-limited settings, the selection process may not reflect the full geographic or socio-economic diversity of Bangladesh. Future studies using population-based sampling methods can validate the representativeness and expand upon these findings. Second, the school- and population-based serosurveys were conducted at different times of the year, which may limit direct comparability; however, because the incidence of enteric fever remains high year-round in Bangladesh, this is unlikely to introduce substantial bias. Third, enteric fever cases for the longitudinal cohort were enrolled from a pediatric hospital, and there were no cases older than 18 years. However, we have observed that the biggest differences in antibody decay dynamics are among young children (under 5 years) and older than 5 years. The unavailability of longitudinal antibody kinetics data beyond 15 years of age compelled us to use the Bangladesh-specific parameters from 5 years and older aged participants to assess the seroincidence in the 16 years and older age group. More extensive study of antibody kinetics data across different age groups and geographic areas would provide a clearer understanding of anti-HlyE immune responses after infection. Fourth, the analysis relied on Bangladesh-specific HlyE IgG dynamics, although IgA may be a better marker for comparing across contexts. Because the HlyE IgG responses were previously found to vary by study site, likely due to differences in the force of infection, this study used a longitudinal antibody kinetics modelled from enteric fever cases in Bangladesh. Alternatively, using a marker that exhibits consistent peaks and decays across settings with different forces of infection, such as HlyE IgA, may be a more feasible approach to scale enteric fever serosurveillance. Finally, we did not implement both community- and school-based approaches within the same area, which limited our ability to compare the two sampling strategies directly. For better comparison and understanding of their relative effectiveness, future studies could consider evaluating both approaches in the same population.

CONCLUSIONS

Our study highlights a substantial burden of enteric fever infections in semi-urban and rural areas of Bangladesh. We demonstrated that a school-based sampling is a cost-effective method for rapidly determining the seroepidemiology of enteric fever. Seroincidence estimates from this method offer valuable insights into the national landscape of enteric fever burden. Since Bangladesh introduced the typhoid conjugate vaccine into the routine immunisation program on 12 October 2025, this approach can also help guide post-introduction monitoring of typhoid and paratyphoid trajectories among children in Bangladesh.

Supplementary Material

Supplement 1

Key points:

This study provides the first multi-site, rapid seroincidence estimates of typhoid and paratyphoid fever across diverse urban and rural settings in Bangladesh, revealing a substantial and previously under-recognized burden, particularly among young children. By measuring antibody responses using a targeted serologic blood test and applying a novel analytical approach based on Bangladesh-specific antibody kinetics to cross-sectional school- and community-based surveys, it addresses critical gaps left by blood culture–based surveillance, which is limited in coverage and sensitivity. Our findings demonstrate that scalable serosurveillance can reliably capture population-level transmission intensity where routine diagnostics are unavailable. These results directly inform post-introduction monitoring and optimization of the typhoid conjugate vaccine program and provide a practical framework for burden estimation and vaccine policy decision-making in other low-resource settings.

Acknowledgements

We express our gratitude to the parents and teachers of all participants included in this study, as well as to the field and laboratory staff of the Child Health Research Foundation (CHRF) in Bangladesh. This study could not have been implemented without the support of local district authorities. We also acknowledge the collaborative efforts of the SIDRAH Foundation, Dhaka, Bangladesh, and Mr Kinkar Ghosh for the successful completion of this project.

Financial support

The study was supported by the Bill & Melinda Gates Foundation, Seattle, USA, through the Sabin Vaccine Institute, Washington, D.C., USA (INV-008335). The serocalculator software development was supported by the National Institute of Allergy and Infectious Diseases, National Institute of Health, Maryland, USA, grant to KA (R21AI176416). The study design was part of the proposal approved by the funder. The funder had no role in data collection, data analysis, or writing of the report.

Footnotes

Potential conflicts of interest

The authors declare that they have no conflicts of interest.

Patient consent statement

Informed consent was obtained from the parents or guardians of all participants. Participants aged 16 to <18 years provided their assent in addition to parental consent. For the community-based surveys, informed written consent was obtained during home visits. For the school-based surveys, school authorities obtained verbal consent from parents or guardians, and the study team communicated later with them by phone to obtain informed verbal consent. This study was approved by the ethical review board of the Bangladesh Shishu Hospital and Institute [(BICH-ERC-01/02/2019) and (BICH-ERC-09/02/2021)].

Contributor Information

Sira Jam Munira, Child Health Research Foundation, Dhaka, Bangladesh..

Naito Kanon, Child Health Research Foundation, Dhaka, Bangladesh..

Nahidul Islam, Child Health Research Foundation, Dhaka, Bangladesh..

Md. Shakiul Kabir, Child Health Research Foundation, Dhaka, Bangladesh.

Anik Sarkar, Child Health Research Foundation, Dhaka, Bangladesh..

Shamsul Alam Polash, Child Health Research Foundation, Dhaka, Bangladesh..

Hafizur Rahman, Child Health Research Foundation, Dhaka, Bangladesh..

Alice S. Carter, Sabin Vaccine Institute, Washington, DC, USA.

Richelle C. Charles, Massachusetts General Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Jason R. Andrews, Stanford University, Stanford, CA, USA.

Stephen P. Luby, Stanford University, Stanford, CA, USA.

Kristen Aiemjoy, University of California Davis School of Medicine, Department of Public Health Sciences, Davis, CA, USA; Mahidol University Faculty of Tropical Medicine, Department of Microbiology and Immunology, Bangkok, Thailand..

Denise O. Garrett, Sabin Vaccine Institute, Washington, DC, USA..

Samir K Saha, Child Health Research Foundation, Dhaka, Bangladesh..

Jessica C. Seidman, Sabin Vaccine Institute, Washington, DC, USA..

Senjuti Saha, Child Health Research Foundation, Dhaka, Bangladesh..

Data availability statements

All data and analysis codes are available to the corresponding authors upon request.

References

  • 1.Stanaway JD, Reiner RC, Blacker BF, et al. The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis 2019; 19:369–381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Piovani D, Figlioli G, Nikolopoulos GK, Bonovas S. The global burden of enteric fever, 2017–2021: a systematic analysis from the global burden of disease study 2021. EClinicalMedicine 2024; 77. Available at: 10.1016/j.eclinm.2024.102883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Garrett DO, Longley AT, Aiemjoy K, et al. Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project. Lancet Glob Health 2022; 10:e978–e988. Available at: 10.1016/S2214-109X(22)00119-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Saha S, Ishtiaque Sayeed KM, Saha S, et al. Hospitalization of Pediatric Enteric Fever Cases, Dhaka, Bangladesh, 2017–2019: Incidence and Risk Factors. Clinical Infectious Diseases 2020; 71:S196–S204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Naheed A, Ram PK, Brooks WA, et al. Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, Bangladesh. International Journal of Infectious Diseases 2010; 14:e93–e99. Available at: 10.1016/j.ijid.2009.11.023. [DOI] [PubMed] [Google Scholar]
  • 6.Antillon M, Saad NJ, Baker S, Pollard AJ, Pitzer VE. The Relationship between Blood Sample Volume and Diagnostic Sensitivity of Blood Culture for Typhoid and Paratyphoid Fever: A Systematic Review and Meta-Analysis. Journal of Infectious Diseases 2018; 218:S255–S267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Voysey M, Pant D, Shakya M, et al. Under-detection of blood culture-positive enteric fever cases: The impact of missing data and methods for adjusting incidence estimates. PLoS Negl Trop Dis 2020; 14:1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bobrovitz N, Arora RK, Cao C, et al. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis. PLoS One 2021; 16:e0252617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Arnold BF, Martin DL, Juma J, et al. Enteropathogen antibody dynamics and force of infection among children in low-resource settings. Elife 2019; 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Salje H, Cummings DAT, Rodriguez-Barraquer I, et al. Reconstruction of antibody dynamics and infection histories to evaluate dengue risk. Nature 2018; 557:719–723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kshatri JS, Bhattacharya D, Praharaj I, et al. Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys. Epidemiol Infect 2021; 149:e139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Watson CH, Baker S, Lau CL, et al. A cross-sectional seroepidemiological survey of typhoid fever in Fiji. PLoS Negl Trop Dis 2017; 11:1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Meiring JE, Shakya M, Khanam F, et al. Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study. Lancet Glob Health 2021; 9:e1688–e1696. Available at: 10.1016/S2214-109X(21)00370-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Pulickal AS, Gautam S, Clutterbuck EA, et al. Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, Nepal. Clinical and Vaccine Immunology 2009; 16:1413–1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Charles RC, Liang L, Khanam F, et al. Immunoproteomic analysis of antibody in lymphocyte supernatant in patients with typhoid fever in Bangladesh. Clinical and Vaccine Immunology 2014; 21:280–285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Andrews JR, Khanam F, Rahman N, et al. Plasma Immunoglobulin A Responses Against 2 Salmonella Typhi Antigens Identify Patients with Typhoid Fever. Clinical Infectious Diseases 2019; 68:949–955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Aiemjoy K, Seidman JC, Saha S, et al. Estimating typhoid incidence from community-based serosurveys: a multicohort study. Lancet Microbe 2022; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Aiemjoy K, Rumunu J, Hassen JJ, et al. Seroincidence of Enteric Fever, Juba, South Sudan. Emerg Infect Dis 2022; 28:2316–2320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Abraham D, Kathiresan L, Sasikumar M, et al. Wastewater surveillance for Salmonella Typhi and its association with seroincidence of enteric fever in Vellore, India. PLoS Negl Trop Dis 2025; 19:e0012373-. Available at: 10.1371/journal.pntd.0012373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Khan A, Kamenskaya P, Rezende I, et al. Seroincidence rate of typhoidal Salmonella in children in Kenya. medRxiv 2025; :2025.06.24.25330223. Available at: http://medrxiv.org/content/early/2025/06/25/2025.06.24.25330223.abstract. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Andrews JR, Vaidya K, Saha S, et al. Healthcare Utilization Patterns for Acute Febrile Illness in Bangladesh, Nepal, and Pakistan : Results from the Surveillance for Enteric Fever in Asia Project. 2020; 71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Saha S, Kanon N, Islam MS, et al. Cohort Profile: Health and Demographic Surveillance System in Mirzapur, Tangail, Bangladesh. medRxiv 2025; :2025.07.21.25331957. Available at: http://medrxiv.org/content/early/2025/07/22/2025.07.21.25331957.abstract. [DOI] [PubMed] [Google Scholar]
  • 23.Weyant C, Hooda Y, Munira SJ, et al. Cost-effectiveness and public health impact of typhoid conjugate vaccine introduction strategies in Bangladesh. Vaccine 2024; Available at: https://linkinghub.elsevier.com/retrieve/pii/S0264410X24003220. Accessed 29 March 2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Charles RC, Sultana T, Alam MM, et al. Identification of Immunogenic Salmonella enterica Serotype Typhi Antigens Expressed in Chronic Biliary Carriers of S. Typhi in Kathmandu, Nepal. PLoS Negl Trop Dis 2013; 7:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Teunis PFMM, van Eijkeren JCHH. Estimation of seroconversion rates for infectious diseases: Effects of age and noise. Stat Med 2020; 39:2799–2814. [DOI] [PubMed] [Google Scholar]
  • 26.Aiemjoy Kristen, Morrison Ezra, Lai Kristina, Siedman Jessica. Serocalculator Data Repository. 2025. Available at: https://osf.io/ne8pc/overview. Accessed 16 December 2025. [Google Scholar]
  • 27.Lai KW, Orwa C, Seidman JC, et al. serocalculator, an R package for estimating seroincidence from cross-sectional serological data. medRxiv 2025; :2025.06.04.25328941. Available at: http://medrxiv.org/content/early/2025/06/06/2025.06.04.25328941.abstract. [Google Scholar]
  • 28.Walker J, Russell P, Kermack L, et al. Leveraging paired serology to estimate the incidence of typhoidal &lt;em&gt;Salmonella&lt;/em&gt; infection in the STRATAA study. medRxiv 2025; :2025.03.15.25324021. Available at: http://medrxiv.org/content/early/2025/03/17/2025.03.15.25324021.abstract. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hancuh M, Walldorf J, Minta AA, et al. Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction - Worldwide, 2018–2022. MMWR Morb Mortal Wkly Rep 2023; 72:171–176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Saha S, Tanmoy AM, Andrews JR, et al. Evaluating PCR-based detection of Salmonella typhi and paratyphi a in the environment as an enteric fever surveillance tool. American Journal of Tropical Medicine and Hygiene 2019; 100:43–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Maude RR, Ghose A, Samad R, et al. A prospective study of the importance of enteric fever as a cause of non-malarial febrile illness in patients admitted to Chittagong Medical College Hospital, Bangladesh. BMC Infect Dis 2016; 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. 2004; 002295. [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1

Data Availability Statement

All data and analysis codes are available to the corresponding authors upon request.


Articles from medRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES